Published in
Taylor and Francis Group, International Journal of Psychiatry in Clinical Practice, 4(26), p. 352-362, 2022
DOI: 10.1080/13651501.2022.2030757
Links
Tools
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme
Journal article published in 2022 by
Ludovic Samalin 
,
Maud Rothärmel,
Lila Mekaoui,
Emeline Gaudré-Wattinne,
Marie-Alix Codet,
Sophie Bouju,
Anne Sauvaget
,
Maud Rothärmel,
Lila Mekaoui,
Emeline Gaudré-Wattinne,
Marie-Alix Codet,
Sophie Bouju,
Anne Sauvaget
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 